Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04233567
Title Infigratinib for the Treatment of Advanced or Metastatic Solid Tumors in Patients With FGFR Gene Mutations
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors Sameek Roychowdhury
Indications

Advanced Solid Tumor

cholangiocarcinoma

Therapies

Infigratinib

Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
Ohio State University Comprehensive Cancer Center Recruiting Columbus Ohio 43210 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field